Comparative Analysis of Shockwave Therapy, Bisphosphonate, and Stem Cells for Osteoporosis
Author Information
Author(s): Cheng Jai-Hong, Chen Cheng-Wei, Chou Wen-Yi, Chen Po-Cheng, Wu Kuan-Ting, Jhan Shun-Wun, Hsu Shan-Ling, Wu Yi-No, Chen Hou-Tsung
Primary Institution: Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine
Hypothesis
This study compares the therapeutic effects of extracorporeal shockwave therapy, bisphosphonate, and human Wharton jelly-derived mesenchymal stem cells in a rat model of osteoporosis.
Conclusion
Aclasta provided the best overall therapeutic response for bone regeneration, while ESWT and WJMSC also showed significant chondroprotective effects.
Supporting Evidence
- All treatments improved bone density and preserved cartilage.
- Aclasta showed the greatest improvements in bone parameters.
- ESWT highlighted non-invasive chondroprotective potential.
- WJMSCs demonstrated regenerative properties for bone and cartilage.
Takeaway
This study looked at different treatments for weak bones in rats and found that one medicine worked best, but other treatments also helped protect the joints.
Methodology
Female rats were assigned to four groups: Sham, OP, ESWT, Aclasta, and WJMSC, with treatments evaluated through micro-CT, serum cytokines, and histopathological analysis.
Potential Biases
Potential bias in treatment effects due to the animal model used.
Limitations
The OVX rat model does not fully represent human osteoporosis, and the long-term effects of ESWT remain unclear.
Participant Demographics
Female Sprague-Dawley rats, approximately 10 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website